Business Standard

Covid vaccine is first step. It'll take years to manufacture and distribute

One estimate puts global vaccine production capacity at up to 6.4 billion doses per year, though this is based on single-dose influenza vaccines.

Coronavirus, vaccine, covid, drugs, tests, clinical trials
Premium

Given these production constraints, governments have previously tended to sign advance purchase agreements with vaccine manufacturers to guarantee access

Adam Kamradt-Scott | The Conversation
The world is hoping a safe and effective Covid-19 vaccine will soon become available. So far, more than 160 candidate vaccines are in development.
Some 31 of these have entered human clinical trials. One of them is Russia’s “Sputnik V”, which was granted approval by the country’s health ministry last week. But the World Health Organisation (WHO) and a large number of international experts have urged Russia to conduct more testing to ensure the vaccine’s safety before using it.
But even if this candidate and others are proven

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in